Pictured: Geoffrey Ku

Geoffrey Y. Ku, MD

Gastrointestinal Medical Oncologist & Cellular Therapist

Areas of Expertise

Conditions I Treat

  • Gastrointestinal cancers and conditions
  • Esophageal cancers and conditions
  • Stomach (gastric) cancer

My Specialties

  • Chemotherapy
  • Immunotherapy
  • CAR T-cell therapy
View all expertise
Dr. Ku's Office Information
Languages: English
Request an Appointment
Our Care Advisors can answer many of your questions. They will connect you with the best healthcare provider for your needs.
Back to top

Get to Know Me

I am a medical oncologist who cares for people with cancer in the gastrointestinal tract, including:

Read more

I graduated from the University of Pennsylvania School of Medicine. I completed an internal medicine residency at NewYork-Presbyterian Hospital at Weill Cornell, followed by a medical oncology fellowship at Memorial Sloan Kettering Cancer Center (MSK). I also spent an additional year at the Ludwig Center for Cancer Immunotherapy at MSK. My research in that time focused on translational correlative assays for the then new field of immunotherapy.

Now, my research focuses on developing new treatments for people with esophageal and gastric cancers. I am interested in exploring the combination of chemotherapy and radiation to treat esophageal cancer. I am also investigating cellular therapy, immunotherapy, and targeted therapies both to cure and to minimize the symptoms of cancer.  

I feel truly privileged to be at MSK. It is a unique and empowering experience to work at an institution whose sole focus is the treatment of cancer and the exploration of ways to improve cancer therapy. We attract staff members from all over the world; all of us have the same focus and dedication to providing expert cancer care.

On a personal note, my team and I strive to treat each patient as an individual. We care for our patients in the same way that we would want our dearest family members and friends to be cared for. I recognize that I am meeting patients and their families at a time of great physical and emotional vulnerability and do my best to uphold the trust and confidence they have in us.

I am currently Head of the Esophagogastric Section in the Gastrointestinal Oncology Service. Since 2020, I have also held an appointment on the Cellular Therapy Service, where we are investigating novel cellular therapies, such as chimeric antigen receptor (CAR) T cell therapy.

Outside of MSK, I have served as a member of the Gastrointestinal Non-Colorectal Cancer Track for the Scientific Program Committee of the American Society of Clinical Oncology (ASCO). I was privileged to serve as the Track Leader for 2015–2016. I am currently a member of the National Cancer Institute’s (NCI’s) Esophagogastric Task Force and NRG Oncology’s Gastrointestinal Non-Colorectal Cancer Core Committee. I was also recently part of a panel organized by the Society for Immunotherapy of Cancer (SITC) to help develop guidelines for the use of immunotherapy in gastrointestinal cancers.

What I Do at MSK

I'm a gastrointestinal (GAS-troh-in-TES-tih-nul) medical oncologist, which is a cancer doctor who specializes in gastrointestinal (GI) cancers. This includes anal, colorectal, esophageal, gastric (stomach), liver, and pancreatic cancers. We also treat GI stromal tumors and neuroendocrine tumors.

A cellular therapy specialist is a doctor with special training in using cell therapies to treat health conditions such as cancer. Therapies can include chimeric antigen receptor (CAR) T cell therapy.

  • Associate Attending Physician
Areas of Expertise

Conditions I Treat

  • Gastrointestinal cancers and conditions
  • Esophageal cancers and conditions
  • Stomach (gastric) cancer
  • Colon cancer
  • Rectal cancer
  • Pancreatic cancer

My Specialties

  • Chemotherapy
  • Immunotherapy
  • CAR T-cell therapy
  • Targeted therapy
Education & Honors

Education

  • MD, University of Pennsylvania School of Medicine

Residencies

  • NewYork-Presbyterian Hospital/Weill Cornell Medical Center

Fellowships

  • Memorial Sloan Kettering Cancer Center

Board Certifications

  • Medical Oncology

Awards and Honors

  • Castle Connolly: America’s Top Doctor (2025)
  • Castle Connolly: Top AAPI Doctor (2024)
  • Castle Connolly: America’s Top Doctor (2024)
  • Top Doctors New York Metro Area, Castle Connolly (2023)
  • Castle Connolly: America's Top Doctors (2023)

Insurance Information

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Don't see your carrier or plan? We can help you understand your coverage.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

If you have questions about insurance, call us at 646-497-9176.

Make an Appointment

Women talking
New Patients
Scheduling an appointment is easy. Click or call 646-497-9053— we’re available 24 hours a day, 7 days a week
Make an Appointment
Current Patients
Request an appointment by logging in to MSK MyChart or calling your Care Team. If you are not enrolled in MSK MyChart, ask your Care Team to send you an invitation. You can also go to MSK MyChart and select “Sign up now.”

Contact and Location

Dr. Ku sees patients at two locations.

Office Phone
Location
New York, NY
Rockefeller Outpatient Pavilion
160 East 53rd Street New York NY 10022
Get Directions
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center
530 East 74th Street New York NY 10021
Get Directions

Looking to see a doctor at a different location? See all MSK locations.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Cellular Therapy Service doctors

See all Gastrointestinal Oncology Service doctors

Clinical Trials

Read more
Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

Publications on PubMed

Visit PubMed for a full listing of Dr. Ku’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.

See all on PubMed

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Geoffrey Y. Ku discloses the following relationships and financial interests:

  • Astellas
    Professional Services and Activities
  • AstraZeneca
    Professional Services and Activities
  • Bayer
    Professional Services and Activities
  • Bristol-Myers Squibb
    Professional Services and Activities
  • I-Mab Biopharma
    Professional Services and Activities
  • Jazz Pharmaceuticals
    Professional Services and Activities
  • Merck & Co Inc.
    Professional Services and Activities
  • Zymeworks Inc.
    Professional Services and Activities

If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures